Skip to main content


Page 2 of 17

  1. Survivors of testicular cancer may experience long-term morbidity following treatment. There is an unmet need to investigate techniques that can differentiate individuals who need additional therapy from those...

    Authors: Ciara Conduit, Thuan Tzen Koh, Michael S Hofman, Guy C Toner, Jeremy Goad, Nathan Lawrentschuk, Keen-Hun Tai, Jeremy H Lewin and Ben Tran
    Citation: Cancer Imaging 2022 22:58
  2. Breast cancer screening is essential in detecting breast tumors, however, the examination is stressful. In this study we analyzed whether humor enhances patient satisfaction.

    Authors: Elisabeth Sartoretti, Thomas Sartoretti, Dow Mu Koh, Sabine Sartoretti-Schefer, Sebastian Kos, Romana Goette, Ricardo Donners, Robyn Benz, Johannes M. Froehlich, Simon Matoori, Peter Dubsky, Tino Plümecke, Rosemarie Forstner, Willibald Ruch, Matthias Meissnitzer, Klaus Hergan…
    Citation: Cancer Imaging 2022 22:57
  3. This study aimed to evaluate the diagnostic capacity of apparent diffusion coefficient (ADC) in predicting pathological Masaoka and T stages in patients with thymic epithelial tumors (TETs).

    Authors: Chao-Chun Chang, Chia-Ying Lin, Li-Ting Huang, Ming-Tsung Chuang, Ying-Hung Lu, Wei-Li Huang, Ying-Yuan Chen, Wu-Wei Lai, Yau-Lin Tseng and Yi-Ting Yen
    Citation: Cancer Imaging 2022 22:56
  4. To compare the diagnostic performance of international hepatocellular carcinoma (HCC) guidelines with gadoxetic acid-enhanced MRI (EOB-MRI) and contrast-enhanced Computed tomography (CECT) and their impact on ...

    Authors: Devang Odedra, Ali Babaei Jandaghi, Rajesh Bhayana, Khaled Y. Elbanna, Osvaldo Espin-Garcia, Sandra E. Fischer, Anand Ghanekar, Gonzalo Sapisochin and Kartik S. Jhaveri
    Citation: Cancer Imaging 2022 22:55
  5. Early tumor shrinkage (ETS) has been identified as a promising imaging biomarker for patients undergoing immunotherapy for several cancer entities. This study aimed to validate the potential of ETS as an imagi...

    Authors: Lukas Müller, Simon Johannes Gairing, Roman Kloeckner, Friedrich Foerster, Eva Maria Schleicher, Arndt Weinmann, Jens Mittler, Fabian Stoehr, Moritz Christian Halfmann, Christoph Düber, Peter Robert Galle and Felix Hahn
    Citation: Cancer Imaging 2022 22:54
  6. To compare [68Ga]PSMA-11 PET-CT, [68Ga]PSMA-11 PET-MRI and MRI in a cohort of prostate cancer (PCa) patients in biochemical recurrence after initial curative therapy.

    Authors: P. A. Glemser, L. T. Rotkopf, C. H. Ziener, B. Beuthien-Baumann, V. Weru, A. Kopp-Schneider, H. P. Schlemmer, A. Dimitrakopoulou-Strauss and C. Sachpekidis
    Citation: Cancer Imaging 2022 22:53
  7. In nasal or sinonasal tumors, orbital invasion beyond periorbita by the tumor is one of the important criteria in the selection of the surgical procedure. We investigated the usefulness of the convolutional ne...

    Authors: Junichi Nakagawa, Noriyuki Fujima, Kenji Hirata, Minghui Tang, Satonori Tsuneta, Jun Suzuki, Taisuke Harada, Yohei Ikebe, Akihiro Homma, Satoshi Kano, Kazuyuki Minowa and Kohsuke Kudo
    Citation: Cancer Imaging 2022 22:52
  8. To develop a radiomics model based on pretreatment whole-liver portal venous phase (PVP) contrast-enhanced CT (CE-CT) images for predicting metachronous liver metastases (MLM) within 24 months after rectal can...

    Authors: Meng Liang, Xiaohong Ma, Leyao Wang, Dengfeng Li, Sicong Wang, Hongmei Zhang and Xinming Zhao
    Citation: Cancer Imaging 2022 22:50
  9. Molecular imaging technologies are increasingly used to diagnose, monitor, and guide treatment of i.e., cancer. In this review, the current status and future prospects of the use of molecular imaging as an in...

    Authors: Imke Boekestijn, Matthias N. van Oosterom, Paolo Dell’Oglio, Floris H. P. van Velden, Martin Pool, Tobias Maurer, Daphne D. D. Rietbergen, Tessa Buckle and Fijs W. B. van Leeuwen
    Citation: Cancer Imaging 2022 22:48
  10. To combine intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) parameters for the evaluation of radiotherapy response in rabbit VX2 malignant bone tumor model.

    Authors: Jia Guo, Weikai Sun, Cheng Dong, Zengjie Wu, Xiaoli Li, Ruizhi Zhou and Wenjian Xu
    Citation: Cancer Imaging 2022 22:47
  11. To establish a nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodules (SSNs) according to the 2021 WHO classification.

    Authors: Qilong Song, Biao Song, Xiaohu Li, Bin Wang, Yuan Li, Wu Chen, Zhaohua Wang, Xu Wang, Yongqiang Yu, Xuhong Min and Dongchun Ma
    Citation: Cancer Imaging 2022 22:46
  12. We aimed to evaluate the prevalence of incidental 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET/CT (SSTR PET/CT) findings, their clinical significance in the need for follow-up, and their risk...

    Authors: Morten Bentestuen, Farid Gossili, Charlotte Elberling Almasi and Helle Damgaard Zacho
    Citation: Cancer Imaging 2022 22:44
  13. High early recurrence (ER) of hepatocellular carcinoma (HCC) after microwave ablation (MWA) represents a sign of aggressive behavior and severely worsens prognosis. The aim of this study was to estimate the ou...

    Authors: Zhaohe Zhang, Jie Yu, Sisi Liu, Linan Dong, Tiefang Liu, Haiyi Wang, Zhiyu Han, Xiaojing Zhang and Ping Liang
    Citation: Cancer Imaging 2022 22:42
  14. The aim of this study is to propose a new TI-RADS and compare it with the American College of Radiology (2017 ACR)-TI-RADS and the 2020 Chinese (2020 C)-TI-RADS.

    Authors: Zhiguang Chen, Yue Du, Linggang Cheng, Yukang Zhang, Shuai Zheng, Rui Li, Wenkai Zhang, Wei Zhang and Wen He
    Citation: Cancer Imaging 2022 22:41
  15. To evaluate the parameters derived from arterial spin labeling (ASL) and multi-b-value diffusion-weighted imaging (DWI) for differentiating retropharyngeal lymph nodes (RLNs) in patients with nasopharyngeal ca...

    Authors: Xiaoduo Yu, Fan Yang, Xue Liu, Yanfeng Zhao, Yujie Li, Meng Lin, Lizhi Xie and Yuqing Shang
    Citation: Cancer Imaging 2022 22:40
  16. Current radiological assessments of 18fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging data in diffuse large B-cell lymphoma (DLBCL) can be time consuming, do not yield real-time information rega...

    Authors: S. Jemaa, J. N. Paulson, M. Hutchings, L. Kostakoglu, J. Trotman, S. Tracy, A. de Crespigny, R. A. D. Carano, T. C. El-Galaly, T. G. Nielsen and T. Bengtsson
    Citation: Cancer Imaging 2022 22:39
  17. Arterial enhancement fraction (AEF), derived from triphasic CT scans, is considered to indirectly reflect the ratio of hepatic arterial perfusion to total perfusion. The purpose of this study was to retrospect...

    Authors: Bin Chai, Dongqiao Xiang, Wei Wang, Yanqiao Ren, Fuquan Wang, Jihua Wang, Guofeng Zhou and Chuansheng Zheng
    Citation: Cancer Imaging 2022 22:38
  18. To evaluate effectivity of a 3D-motion correction algorithm in C-Arm CTs (CACT) with limited image quality (IQ) during transarterial chemoembolization (TACE).

    Authors: Lena S. Becker, Cornelia L. A. Dewald, Christian von Falck, Thomas Werncke, Sabine K. Maschke, Roman Kloeckner, Frank K. Wacker, Bernhard C. Meyer and Jan B. Hinrichs
    Citation: Cancer Imaging 2022 22:37
  19. We aimed to assess the clinical value of 18F-PSMA-1007 and 68Ga-PSMA-11 PET/MRI in the gross tumor volume (GTV) delineation of radiotherapy for prostate cancer (PCa).

    Authors: Yan-Nan Zhang, Zhen-Guo Lu, Shuai-Dong Wang, Xin Lu, Lei-Lei Zhu, Xu Yang, Li-Ping Fu, Jun Zhao, Hai-Feng Wang and Zuo-Lin Xiang
    Citation: Cancer Imaging 2022 22:36
  20. To investigate the magnetic resonance imaging (MRI)-based radiomics value in predicting the survival of patients with locally advanced cervical squamous cell cancer (LACSC) treated with concurrent chemoradioth...

    Authors: Xiaomiao Zhang, Jingwei Zhao, Qi Zhang, Sicong Wang, Jieying Zhang, Jusheng An, Lizhi Xie, Xiaoduo Yu and Xinming Zhao
    Citation: Cancer Imaging 2022 22:35
  21. To evaluate the anatomic site(s) of initial disease progression in patients with castration resistant metastatic prostate cancer (mCRPC) in the presence or absence of pre-treatment visceral metastases while on...

    Authors: Kathleen Ruchalski, Hyun J. Kim, Michael Douek, Steven Raman, Maitraya Patel, Victor Sai, Antonio Gutierrez, Benjamin Levine, Cheryce Fischer, Martin Allen-Auerbach, Pawan Gupta, Heidi Coy, Bianca Villegas, Matthew Brown and Jonathan Goldin
    Citation: Cancer Imaging 2022 22:34
  22. The distinction between true disease progression and radiation necrosis after stereotactic radiosurgery to intracranial metastases is a common, but challenging, clinical scenario. Improvements in systemic ther...

    Authors: Arian Lasocki, Joseph Sia and Stephen L. Stuckey
    Citation: Cancer Imaging 2022 22:33
  23. Neuroblastoma (NB) is the most common tumour in children younger than 5 years old and notable for highly heterogeneous. Our aim was to quantify the intra-tumoural metabolic heterogeneity of primary tumour lesi...

    Authors: Jun Liu, Yukun Si, Ziang Zhou, Xu Yang, Cuicui Li, Luodan Qian, Li Juan Feng, Mingyu Zhang, Shu Xin Zhang, Jie Liu, Ying Kan, Jianhua Gong and Jigang Yang
    Citation: Cancer Imaging 2022 22:32
  24. The goals of precision oncology are to provide targeted drug therapy based on each individual’s specific tumor biology, and to enable the prediction and early assessment of treatment response to allow treatmen...

    Authors: Christine E. Edmonds, Sophia R. O’Brien, David A. Mankoff and Austin R. Pantel
    Citation: Cancer Imaging 2022 22:31
  25. Previous studies have indicated that T1 relaxation time could be utilized for the analysis of tissue characteristics. T1 mapping technology has been gradually used on research of body tumor. In this study, the...

    Authors: Juan Li, Xuemei Gao, Marcel Dominik Nickel, Jingliang Cheng and Jinxia Zhu
    Citation: Cancer Imaging 2022 22:30
  26. The aim of this study was to evaluate the clinical utility of SPECT/CT (imaging of uptake in tumor lesions and additional findings) and the additional value of planar imaging in order to simplify clinical imag...

    Authors: Else A. Aalbersberg, Daphne M. V. de Vries–Huizing, Margot E. T. Tesselaar, Marcel P. M. Stokkel and Michelle W. J. Versleijen
    Citation: Cancer Imaging 2022 22:29
  27. In neuro-oncology, dynamic susceptibility contrast magnetic resonance (DSC-MR) perfusion imaging emerged as a tool to aid in the diagnostic work-up and to surveil effectiveness of treatment. However, it is bel...

    Authors: Valentina Kouwenberg, Lusien van Santwijk, Frederick J. A. Meijer and Dylan Henssen
    Citation: Cancer Imaging 2022 22:28
  28. Melanoma is the most aggressive form of skin cancer, with a tendency to metastasise to any organ of the human body. While the most common body organs affected include liver, lungs, brain and soft tissues, spre...

    Authors: Eva Mendes Serrao, Emily Joslin, Victoria McMorran, Caroline Hough, Cheryl Palmer, Sarah McDonald, Emma Cargill, Ashley S. Shaw, Brent O’Carrigan, Christine A. Parkinson, Pippa G. Corrie and Timothy J. Sadler
    Citation: Cancer Imaging 2022 22:27
  29. The assessment of metastatic breast cancer (MBC) can be limited with routine imaging such as computed tomography (CT) especially in bone-only or bone-predominant disease. This analysis investigates the effects...

    Authors: Basrull N. Bhaludin, Nina Tunariu, Nishanthi Senthivel, Amna Babiker, Neil D. Soneji, Nabil Hujairi, Bhupinder Sharma, Sophie E. McGrath, Alicia F. Okines, Alistair E. Ring, Christina Messiou, Kate Downey and Dow-Mu Koh
    Citation: Cancer Imaging 2022 22:26
  30. Neuroendocrine neoplasia (NEN) is an umbrella term that includes a widely heterogeneous disease group including well-differentiated neuroendocrine tumours (NETs), and aggressive neuroendocrine carcinomas (NECs...

    Authors: Amir Iravani, Ashwin Singh Parihar, Timothy Akhurst and Rodney J. Hicks
    Citation: Cancer Imaging 2022 22:25
  31. To systematically review and perform meta-analysis to evaluate the prognostic value of cervical nodal necrosis (CNN) on the staging computed tomography/magnetic resonance imaging (MRI) of nasopharyngeal carcin...

    Authors: Qi-Yong H. Ai, Kuo Feng Hung, Tiffany Y. So, Frankie K. F. Mo, Wing Tsung Anthony Chin, Edwin P. Hui, Brigette B. Y. Ma, Michael Ying and Ann D. King
    Citation: Cancer Imaging 2022 22:24
  32. Transcatheter arterial chemoembolization (TACE) is the mainstay of therapy for intermediate-stage hepatocellular carcinoma (HCC); yet its efficacy varies between patients with the same tumor stage. Accurate pr...

    Authors: Lu Zhang, Yicheng Jiang, Zhe Jin, Wenting Jiang, Bin Zhang, Changmiao Wang, Lingeng Wu, Luyan Chen, Qiuying Chen, Shuyi Liu, Jingjing You, Xiaokai Mo, Jing Liu, Zhiyuan Xiong, Tao Huang, Liyang Yang…
    Citation: Cancer Imaging 2022 22:23
  33. Radiomics plays an important role in the field of oncology. Few studies have focused on the identification of factors that may influence the classification performance of radiomics models. The goal of this stu...

    Authors: Yuqi Sun, Simin Wang, Ziang Liu, Chao You, Ruimin Li, Ning Mao, Shaofeng Duan, Henry S. Lynn and Yajia Gu
    Citation: Cancer Imaging 2022 22:22
  34. To evaluate the value of Color Doppler Flow Imaging (CDFI), Superb Microvascular Imaging (SMI) and Contrast-enhanced Ultrasound Microflow Imaging (MFI) in display the microvascular blood flow signals in renal ...

    Authors: Yiran Mao, Jie Mu, Jing Zhao, Fan Yang and Lihui Zhao
    Citation: Cancer Imaging 2022 22:21
  35. A scoring system focusing on the risk of muscle layer invasion by Bladder cancer (BCa) has been released, Vesical Imaging - Radiological and Data System (VI-RADS), with a growing interest in evaluating its dia...

    Authors: Thaisa Gvozdenovic Medina Bricio, Gabriel Lion Gouvea, Rafael Vasconcelos Barros, Fernando Chahud, Jorge Elias Jr, Rodolfo B. Reis and Valdair F. Muglia
    Citation: Cancer Imaging 2022 22:20
  36. Currently, most CNS tumors require tissue sampling to discern their molecular/genomic landscape. However, growing research has shown the powerful role imaging can play in non-invasively and accurately detectin...

    Authors: Saivenkat Vagvala, Jeffrey P. Guenette, Camilo Jaimes and Raymond Y. Huang
    Citation: Cancer Imaging 2022 22:19
  37. The goal of this study is to develop and validate a radiomics nomogram integrating the radiomics features from DCE-MRI and clinical factors for the preoperative diagnosis of axillary lymph node (ALN) metastasi...

    Authors: Deling Song, Fei Yang, Yujiao Zhang, Yazhe Guo, Yingwu Qu, Xiaochen Zhang, Yuexiang Zhu and Shujun Cui
    Citation: Cancer Imaging 2022 22:17
  38. This translational study explores multi-tracer PET imaging for the non-invasive detection of the IDH1 mutation which is a positive prognostic factor in glioma.

    Authors: Alexandra Clément, Timothee Zaragori, Romain Filosa, Olga Ovdiichuk, Marine Beaumont, Charlotte Collet, Emilie Roeder, Baptiste Martin, Fatiha Maskali, Muriel Barberi-Heyob, Celso Pouget, Matthieu Doyen and Antoine Verger
    Citation: Cancer Imaging 2022 22:16
  39. To compare image quality, lesion detection and patient comfort of 3T prostate MRI using a combined rigid two-channel phased-array endorectal coil and an external phased-array coil (ERC-PAC) compared to externa...

    Authors: Sara Lewis, Aasrith Ganti, Pamela Argiriadi, Ally Rosen, Stefanie Hectors, Sahar Semaan, Christopher Song, Steve Peti, Maxwell Segall, Kezia George, Vaneela Jaikaran, Sebastian Villa, David Kestenbaum, Nicholas Voutsinas, John Doucette, Ashutosh Tewari…
    Citation: Cancer Imaging 2022 22:15
  40. Hepatocellular carcinoma (HCC) with symptomatic portal hypertension (SPH) has poor prognosis. A transjugular intrahepatic portosystemic shunt (TIPS) relieves SPH, but its application in HCC remains unclear. We...

    Authors: Huzheng Yan, Zhenkang Qiu, Zhanwang Xiang, Kai Feng, Mingsheng Huang and Fei Gao
    Citation: Cancer Imaging 2022 22:13
  41. Elastography is an addition to grey-scale ultrasonic examination that has gained substantial traction within the last decade. Strain ratio (SR) has been incorporated as a semiquantitative measure within strain...

    Authors: Timothy Musila Mutala, Gladys N. Mwango, Angeline Aywak, Dania Cioni and Emanuele Neri
    Citation: Cancer Imaging 2022 22:12
  42. The optimal duration of immune checkpoint blockade (ICB) therapy is not well established. Active residual disease is considered prohibitive for treatment discontinuation and its detection by diagnostic CT imag...

    Authors: Justin Ferdinandus, Anne Zaremba, Lisa Zimmer, Lale Umutlu, Robert Seifert, Francesco Barbato, Selma Ugurel, Eleftheria Chorti, Viktor Grünwald, Ken Herrmann, Dirk Schadendorf, Wolfgang Peter Fendler and Elisabeth Livingstone
    Citation: Cancer Imaging 2022 22:11
  43. Accurate pretreatment prediction for disease progression of nasopharyngeal carcinoma is key to intensify therapeutic strategies to high-risk individuals. Our aim was to evaluate the value of baseline MRI-based...

    Authors: Dan Bao, Zhou Liu, Yayuan Geng, Lin Li, Haijun Xu, Ya Zhang, Lei Hu, Xinming Zhao, Yanfeng Zhao and Dehong Luo
    Citation: Cancer Imaging 2022 22:10

Official journal of

Annual Journal Metrics

Download journal leaflet